162 related articles for article (PubMed ID: 6364692)
1. A clinico-pathological and immunological study of unfavourable non-Hodgkin lymphomas. Comparison of the Rappaport and Kiel classifications.
Lindemalm C; Christensson B; Johansson B; Mellstedt H; Ost A; Biberfeld P
Acta Pathol Microbiol Immunol Scand A; 1983 Nov; 91(6):435-43. PubMed ID: 6364692
[TBL] [Abstract][Full Text] [Related]
2. Correlation of immunophenotype to morphology in unfavourable non-Hodgkin lymphoma.
Christensson B; Lindemalm C; Johansson B; Mellstedt H; Ost A; Biberfeld P
Acta Pathol Microbiol Immunol Scand A; 1983 Nov; 91(6):425-33. PubMed ID: 6364691
[TBL] [Abstract][Full Text] [Related]
3. Surface phenotyping, histology and the nature of non-Hodgkin lymphoma in 157 patients.
Habeshaw JA; Catley PF; Stansfeld AG; Brearley RL
Br J Cancer; 1979 Jul; 40(1):11-34. PubMed ID: 314300
[TBL] [Abstract][Full Text] [Related]
4. Histopathological correlation of the Kiel with the original Rappaport classification of malignant non-hodgkin lymphomas.
Krüger GR; Grisar T; Lennert K; Schwarze EW; Brittinger G
Blut; 1981 Sep; 43(3):167-81. PubMed ID: 7343013
[TBL] [Abstract][Full Text] [Related]
5. Morphological classification of non-Hodgkin malignant lymphoma. II. Comparison between Rappaport's classification and the Kiel classification.
Glimelius B; Hagberg H; Sundström C
Scand J Haematol; 1983 Jan; 30(1):13-24. PubMed ID: 6836219
[TBL] [Abstract][Full Text] [Related]
6. The Rappaport classification of non-Hodgkin's lymphomas: a closer look using other proposed classifications.
Garvin AJ; Simon R; Young RC; DeVita VT; Berard CW
Semin Oncol; 1980 Sep; 7(3):234-43. PubMed ID: 6998002
[TBL] [Abstract][Full Text] [Related]
7. A clinicopathologic study in advanced non-Hodgkin's lymphomas treated with sequential non-cross-resistant regimens: comparison of the working formulation with the Rappaport and Kiel classifications.
Monfardini S; Rilke F; Valagussa P; Bajetta E; Canetta R; Buzzoni R; Giardini R; Viviani S
Eur J Cancer Clin Oncol; 1984 May; 20(5):609-17. PubMed ID: 6203753
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of lymphocytic surface markers and histology in adult non-Hodgkin's lymphoma.
Bloomfield CD; Kersey JH; Brunning RD; Gajl-Peczalska KJ
Cancer Treat Rep; 1977 Sep; 61(6):963-70. PubMed ID: 332359
[TBL] [Abstract][Full Text] [Related]
9. [Pathologicoanatomical characteristics of the most important forms of non-Hodgkin malignant lymphomas (based on the Kiel classification)].
Shtern RD
Arkh Patol; 1980; 42(11):71-80. PubMed ID: 7004413
[TBL] [Abstract][Full Text] [Related]
10. Surface markers and functional properties of non-Hodgkin's lymphoma cells in relation to histology.
Bom-Van Noorloos AA; Splinter TA; van Heerde P; van Beek AA; Melief CJ
Cancer; 1978 Oct; 42(4):1804-17. PubMed ID: 152144
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the working formulation of non-Hodgkin's lymphoma with the Rappaport, Kiel, and Lukes & Collins classifications. Translational value and prognostic significance based on review of 658 patients treated at a single institution.
Ersbøll J; Schultz HB; Hougaard P; Nissen NI; Hou-Jensen K
Cancer; 1985 May; 55(10):2442-58. PubMed ID: 3986740
[TBL] [Abstract][Full Text] [Related]
12. [Introduction to the modern classifications of the non-Hodgkin malignant lymphomas (author's transl)].
Heimann R; Van den Heule B
Dermatologica; 1978; 157(6):345-56. PubMed ID: 309837
[TBL] [Abstract][Full Text] [Related]
13. The Lukes-Collins and Kiel classifications for non-Hodgkin lymphomas. A retrospective study considering both classifications and their relationships to stage, sex, age, and survival.
Blanco G; Alavaikko M; Apaja-Sarkkinen M; Taskinen PJ
Anticancer Res; 1986; 6(2):267-79. PubMed ID: 3707063
[TBL] [Abstract][Full Text] [Related]
14. Rappaport classification of non-Hodgkin's lymphoma: histologic features and clinical significance.
Byrne GE
Cancer Treat Rep; 1977 Sep; 61(6):935-44. PubMed ID: 332357
[TBL] [Abstract][Full Text] [Related]
15. Immune marker expression in 53 lymphomas of high-grade malignancy.
Pallesen G; Madsen M; Schifter S
Histopathology; 1983 Nov; 7(6):841-57. PubMed ID: 6689315
[TBL] [Abstract][Full Text] [Related]
16. A critical analysis of the classifications of non-Hodgkin's lymphomas.
Nathwani BN
Cancer; 1979 Aug; 44(2):347-84. PubMed ID: 383253
[TBL] [Abstract][Full Text] [Related]
17. Immunologic aspects and pathology of the malignant lymphomas.
Berard CW; Jaffe ES; Braylan RC; Mann RB; Nanba K
Cancer; 1978 Aug; 42(2 Suppl):911-21. PubMed ID: 356957
[TBL] [Abstract][Full Text] [Related]
18. Clinical and prognostic relevance of the Kiel classification of non-Hodgkin lymphomas results of a prospective multicenter study by the Kiel Lymphoma Study Group.
Brittinger G; Bartels H; Common H; Dühmke E; Fülle HH; Gunzer U; Gyenes T; Heinz R; König E; Meusers P
Hematol Oncol; 1984; 2(3):269-306. PubMed ID: 6384008
[TBL] [Abstract][Full Text] [Related]
19. Clinico-pathological correlations in the Kiel classification of non-Hodgkin's lymphomata in children.
Garwicz S; Landberg T; Lindberg LG; Akerman M
Scand J Haematol; 1978 Feb; 20(2):171-80. PubMed ID: 635468
[TBL] [Abstract][Full Text] [Related]
20. [B-cell lymphomas (non-Hodgkin's lymphomas of B type) in children--morphologic and immunologic spectrum].
Schwarze EW; Pileri S; Stein H; Palestro G; Tolksdorf G
Klin Padiatr; 1982; 194(4):226-32. PubMed ID: 6982372
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
